COMBINATION THERAPY IN RA - SULFASALAZINE AND METHOTREXATE

被引：0
|
作者：
HAAGSMA, C [1 ]
VANRIEL, P [1 ]
VANDEPUTTE, L [1 ]
机构：
[1] UNIV HOSP NIJMEGEN,DEPT RHEUMATOL,6500 HB NIJMEGEN,NETHERLANDS
来源：
BRITISH JOURNAL OF RHEUMATOLOGY | 1992年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [21] COMBINATION OF METHOTREXATE AND SULFASALAZINE VS METHOTREXATE ALONE - A RANDOMIZED OPEN CLINICAL-TRIAL IN RHEUMATOID-ARTHRITIS PATIENTS RESISTANT TO SULFASALAZINE THERAPY
    HAAGSMA, CJ
    VANRIEL, PLCM
    DEROOIJ, DJRAM
    VREE, TB
    RUSSEL, FJM
    VANTHOF, MA
    VANDEPUTTE, LBA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (11): : 1049 - 1055
  • [22] Methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) combination therapy in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 3 years.
    ODell, J
    Haire, C
    Drymalski, W
    Palmer, W
    Eckhoff, PJ
    Maloley, P
    Klassen, L
    Wees, S
    Klein, H
    Moore, G
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 578 - 578
  • [23] Is combination therapy with methotrexate and intramuscular gold an efficacious method of treatment for RA?
    Audrey Lee Fan
    Daniel E Furst
    Nature Clinical Practice Rheumatology, 2005, 1 (1): : 12 - 13
  • [24] Combination DMARD therapy with methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 5 years.
    O'Dell, J
    Paulsen, G
    Haire, C
    Palmer, W
    Wees, S
    Eckhoff, J
    Klassen, L
    Moore, G
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S132 - S132
  • [25] Comparison of efficacy and tolerability of triple combination therapy (methotrexate plus sulfasalazine plus hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis
    Gubar, E. E.
    Bochkova, A. G.
    Bunchuk, N., V
    TERAPEVTICHESKII ARKHIV, 2008, 80 (05) : 25 - 30
  • [26] The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis
    Furst, DE
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (01) : 39 - 40
  • [27] LIVER TOXICITY IS RARE IN RA PATIENTS USING COMBINATION THERAPY WITH LEFLUNOMIDE AND METHOTREXATE
    Alves, J. A. N. R.
    Zerwes, N.
    Morato, E. F.
    Zimmermann, A. F.
    Castro, G. R. W.
    Neves, F. S.
    Ribeiro, G.
    Pereira, I. A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S42 - S42
  • [28] Drug survival of sulfasalazine and methotrexate: Single versus combination.
    vanGastel, AM
    vanRiel, PLCM
    vandePutte, LBA
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 969 - 969
  • [29] EFFICACY OF COMBINATION THERAPY OF METHOTREXATE WITH HYDROXYCHLOROQUINE OR SULFASALAZINE IN RHEUMATOID ARTHRITIS PATIENTS IN KUMAON REGION: A COMPARATIVE STUDY
    Bharat, Suyash
    Srivastava, Bhavana
    Singh, Paramjeet
    Bhardwaj, Reena
    Gaur, Sanjay
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (51): : 3403 - 3407
  • [30] Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naive patients with early RA
    Lie, Elisabeth
    Uhlig, Till
    van der Heijde, Desiree
    Rodevand, Erik
    Kalstad, Synove
    Kaufmann, Cecilie
    Mikkelsen, Knut
    Kvien, Tore K.
    RHEUMATOLOGY, 2012, 51 (04) : 670 - 678
12345